Cardiac Arrhythmia Monitoring Devices Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Cardiac arrhythmia monitoring devices are used in hospitals, clinics, and increasingly in home and ambulatory settings to continuously or intermittently track cardiac electrical activity for diagnostic and post-treatment purposes. The global market is valued at approximately USD 119.46 billion in 2025 and is forecast to grow at a compound annual rate of about 23.42%, one of the fastest expansion rates among cardiovascular device categories. Demand spans both consumer-grade wearables with ECG capabilities and FDA-cleared clinical-grade telemetry and implantable monitors.

• •Estimated 2025 market value: ~USD 119.46 billion
• •Compound annual growth rate (CAGR): ~23.42%
• •Demand spans clinical telemetry, implantable recorders, Holter/event monitors, and wearable ECG devices

Rising incidence of atrial fibrillation, coronary artery disease, and lifestyle-related cardiovascular conditions is expanding the addressable patient pool worldwide. Aging demographics in North America, Europe, and East Asia are increasing both arrhythmia prevalence and the need for long-term monitoring. Technological advances in miniaturization, biosensors, Bluetooth connectivity, and AI-driven arrhythmia detection algorithms are making devices more accurate, comfortable, and suitable for remote use, while reimbursement expansion for ambulatory cardiac monitoring is accelerating clinical adoption.

• •Aging populations and rising AFib prevalence are expanding the patient base
• •Miniaturization, AI-based detection, and wearable form factors are improving clinical utility
• •Reimbursement coverage for ambulatory and remote cardiac monitoring is broadening in major markets

By product, the market includes Holter monitors, event monitors, mobile cardiac telemetry (MCT), implantable loop recorders (ILRs), and ECG-capable wearable devices, with MCT and wearables representing the fastest-growing sub-segments. By end user, hospitals remain the largest channel, but ambulatory care, home healthcare, and diagnostic laboratories are gaining share as care shifts outside traditional facilities. North America holds the leading regional share due to established reimbursement and high diagnosis rates, while Asia-Pacific is expected to record the strongest growth on the back of improving healthcare access and large patient populations in China, India, and Japan.

• •Product mix: Holter monitors, event monitors, MCT, ILRs, and wearable ECG devices
• •End users: hospitals, ambulatory care, home healthcare, and diagnostic labs
• •Regionally: North America leads; Asia-Pacific is the fastest-growing region

What are the recent trends and outlook?

The market is shifting decisively toward continuous, connected, and consumer-friendly monitoring through patch-based devices and smartwatch-class wearables capable of clinical-grade ECG capture. Artificial intelligence is being embedded across the value chain to automate rhythm classification, reduce false positives, and triage alerts for clinicians, which supports scalable remote monitoring programs. Looking ahead, integration with telehealth platforms, expansion of value-based reimbursement, and growing use in post-stroke and post-ablation follow-up are expected to sustain double-digit growth well beyond the current forecast window.

• •Patch monitors and AI-enabled wearables are reshaping the competitive set
• •Remote monitoring and telehealth integration are becoming standard of care
• •Long-term outlook supports sustained high-single-digit to low-double-digit growth through the 2030s